The recent development of the cancer stem cell (CSC) model has been heralded as a new
era in thyroid cancer research. The aim of this study was to evaluate the presence of CD44+ …

We hypothesized that cancer stem cells (CSCs) are responsible for the poor outcome and
aggressive clinicopathological factors. We surveyed the expression of selected CSC …

Cancer stem cell (CSC) markers have prognostic significance in various cancers, but their
clinical significance in papillary thyroid carcinoma (PTC) has not been demonstrated. In this …

Background: Identifying accurate prognostic molecular markers for papillary thyroid
carcinoma (PTC) is important because many patients with PTC may be erroneously …

Fine needle aspiration biopsy (FNAB) is a standard procedure for the detection of thyroid
nodules malignancy, yet 10‐25% of the sample diagnosed may go undetermined or …

Background Thyroid cancer is one of the most commonly detected cancers worldwide, and
papillary thyroidal carcinoma (PTC) accounts for the majority of thyroid cancers. In contrast …

Results Six TCSC markers were involved, among which CD133, CD44, CD24, CD15 and
ALDH1 were associated with the prognosis of thyroid cancer. Conclusions However, the …

Background and Objectives To investigate the expression profiles of cancer stem cells
(CSCs) markers CD133 and CD44 in a cohort of medullary thyroid carcinoma (MTC) …

Context: Special populations of cells that can efficiently initiate tumor growth have been
characterized, and this feature supports the cancer stem cell theory. These cancer stem cell …

Cancer stem-like cells (CSCs) play important roles in cancer initiation and progression.
CSCs have been isolated using several markers, but those for thyroid CSCs remain to be …